ARENA: GOOD TRIAL RESULTS FROM THIS BIOTECH, OVER 400% GAIN POSSIBLE IN A BUYOUT $ARNA
This post was just published on ZYX Buy Change Alert. Arena stock (ARNA) is long from $16.20. ARNA is trading at $40.75 as of this writing, up $9.86 for the day. It has traded as high as $44.44. The company reported impressive results from a Phase II trial of its ulcerative colitis drug. Previously we have stated that in a buyout, In the event of a buyout, a price in the zone of $44 to $52 is possible. Based on the trial results, we are revising the target zone in a buyout to $75 to $88. The new buy zone for Arena is $28 to